Form D — Zero Point Five Therapeutics, Inc.
0002054934-25-000002 · filed Apr 17, 2025
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $5,333,250
- Total sold
- $4,299,420
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Zero Point Five Therapeutics, Inc.
- CIK
- 1985295
- Entity
- Corporation
- Jurisdiction
- DISTRICT OF COLUMBIA
- Year incorporated
- —
- Address
- 915 S. EATON STREET
BALTIMORE, MD 21224 - Phone
- 301-327-0118
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Joseph Amprey III · Executive OfficerBaltimore, MD Find on LinkedIn ↗
-
Ben Auspitz · DirectorBaltimore, MD Find on LinkedIn ↗
-
Jodi Jahic · DirectorBaltimore, MD Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗